Researchers at Mayo Clinic in Phoenix have reported a promising early experience with performing extraperitoneal robot-assisted radical prostatectomy (RARP) procedures on an outpatient basis. Eleven ...
May 12, 2011, 10:46 AM EDT / Source: GlobeNewswire PEABODY, Mass., May 12, 2011 (GLOBE NEWSWIRE) -- BK Medical, a wholly owned subsidiary of Analogic Corporation (Nasdaq:ALOG), will showcase its new ...
Robot-assisted radical prostatectomy (RARP) is comparable to conventional RP with regard to biochemical recurrence-free survival (BCRFS) in men with high-grade prostate cancer (PCa), study findings ...
Australian urologists are now using Orthocell’s flagship nerve repair product Remplir during prostate cancer surgery in a promising new application aimed at reducing post-surgical complications caused ...
Globally Significant Opportunity Emerges as Remplir is used in Nerve-Sparing Prostate Cancer Surgery
Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ --Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or ...
TipRanks on MSN
Orthocell Expands Remplir’s Use in Prostate Cancer Surgeries
Orthocell Ltd ( ($AU:OCC) ) just unveiled an announcement. Orthocell Ltd has announced the use of its nerve repair device, Remplir, in ...
Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introduced to Urologists in Australia ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback